𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ChemInform Abstract: The Influence of Structure on the Activity and Toxicity of Pt anti-Cancer Drugs

✍ Scribed by T. W. HAMBLEY

Publisher
John Wiley and Sons
Year
2010
Weight
24 KB
Volume
29
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

On the influence of protein binding on p
On the influence of protein binding on pharmacological activity of drugs
✍ Leonid M. Berezhkovskiy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 1 views

The effect of variable protein binding (taken as independent parameter) on pharmacological activity of drugs is considered in terms of the exposure or the steady state concentration of unbound drug at targeted tissue. Based on the application of the parallel tube or dispersion models it is shown tha

ChemInform Abstract: The Electrocatalyti
ChemInform Abstract: The Electrocatalytic Reduction of NO3- on Pt, Pd and Pt + Pd Electrodes Activated with Ge.
✍ J. F. E. GOOTZEN; P. G. J. M. PEETERS; J. M. B. DUKERS; L. LEFFERTS; W. VISSCHER πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 32 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Experimental studies on the role of anti
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
✍ Thomas M. Behr; Stavros Memtsoudis; Robert M. Sharkey; Rosalyn D. Blumenthal; Ro πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 204 KB πŸ‘ 2 views

Whereas bivalent fragments have been widely used for radio-immunotherapy, no systematic study has been published on the therapeutic performance of monovalent conjugates in vivo. The aim of our study was, therefore, to determine the therapeutic performance of 131 I-labeled Fab as compared to bivalent